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Evaporative emissionsIn compliance with the Clean Air Act regulations for fuel and fuel additive registration, the petroleum
industry, additive manufacturers, and oxygenate manufacturers have conducted comparative toxicology
testing on evaporative emissions of gasoline alone and gasoline containing fuel oxygenates. To mimic real
world exposures, a generation method was developed that produced test material similar in composition
to the re-fueling vapor from an automotive fuel tank at near maximum in-use temperatures. Gasoline
vapor was generated by a single-step distillation from a 1000-gallon glass-lined kettle wherein approx-
imately 15–23% of the starting material was slowly vaporized, separated, condensed and recovered as
test article. This fraction was termed vapor condensate (VC) and was prepared for each of the seven test
materials, namely: baseline gasoline alone (BGVC), or gasoline plus an ether (G/MTBE, G/ETBE, G/TAME,
or G/DIPE), or gasoline plus an alcohol (G/EtOH or G/TBA). The VC test articles were used for the inhala-
tion toxicology studies described in the accompanying series of papers in this journal. These studies
included evaluations of subchronic toxicity, neurotoxicity, immunotoxicity, genotoxicity, reproductive
and developmental toxicity. Results of these studies will be used for comparative risk assessments of gas-
oline and gasoline/oxygenate blends by the US Environmental Protection Agency.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction
In 1994, the Environmental Protection Agency (EPA) issued a
ﬁnal rule under the Clean Air Act (CAA) which adds new health
effects information and testing requirements to the Agency’s exist-
ing registration program for motor vehicle fuels and fuel additives
(Registration of Fuels, 2013: § 79.56; Clean Air Act, 2012). The rule,
referred to as the ‘‘211(b)’’ rule, required additional actions that
must be taken to register or maintain product registration. Under
the new registration program, producers of current and new motor
vehicle fuel and fuel additives are required to provide information
and test results to EPA regarding the composition of emissions
from their products and the potential effects of these emissions
on the public health and welfare. These new data requirements
supplemented the existing registration requirements.To help fulﬁll the new 211(b) requirements for gasoline and
diesel fuel, the American Petroleum Institute organized the
211(b) Research Group (‘‘Research Group’’). The Research Group
is an unincorporated group of over two hundred fuel, oxygenate,
and fuel additive manufacturers afﬁliated by contractual obligation
to meet the Tier 1 and Tier 2 testing requirements of
Section 211(b)(2) and 211(e) of the Clean Air Act.
The Research Group’s purpose was to address two of the three
categories of fuel outlined in the 211(b) rule (40 CFR 79.56).
Membership in the Research Group is open to any company which
has an interest in the registration of these products with EPA. The
Research Group tested; (1) ‘‘baseline’’ fuel groups which contain no
elements other than carbon, hydrogen, oxygen, nitrogen and sulfur,
and for gasoline contain less than 1.5% oxygen by weight, and for
diesel contain less than 1.0% oxygen, and (2) ‘‘non-baseline’’ fuel
groups which contain only the elements listed above but are either
derived from nonconventional sources of oil, or contain in excess of
1.5% or 1.0% oxygen by weight for gasoline and diesel respectively.
Oxygenates in non-baseline fuel groups tested by the Research
Group were; ethanol (EtOH), tertiary-butyl alcohol (TBA), methyl
tertiary-butyl ether (MTBE), ethyl tertiary-butyl ether (ETBE),
tertiary-amyl methyl ether (TAME) and di-isopropyl ether (DIPE).
Table 1
Baseline gasoline fuel properties.
Property ASTM
method
EPA
speciﬁcations a
RF-A-BG b
API gravity D 4052 57.4 ± 0.3 57.7
Sulfur, ppm D 4294 339 ± 25 320
Benzene, volume % GC 1.53 ± 0.3 1.44
RVP, psi D 323 8.7 ± 0.3 8.7
Octane, (R + M)/2 D 2699 D 2700 87.3 ± 0.5 87.5
Distillation
parameters:
D 86
10%, F 128 ± 5 126
50%, F 218 ± 5 216
90%, F 330 ± 5 332
Hydrocarbon type
(volume %)
D 1319
Aromatics 32.0 ± 2.7 31.7
Oleﬁns 9.2 ± 2.5 11.6
Saturates 58.8 ± 2.0 56.7
Additive types: Treat rate used
(lbs/1000 barrels)
Required Deposit control 107
Corrosion inhibitor 5
Demulsiﬁer 2
Anti-oxidant 5
Metal deactivator 1
Permissible Anti-static 0.5
a 40 CFR79.55.
b Phillips 66 petroleum data.
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gory of fuel groups, namely atypical fuel groups, which consist of
fuels or fuel additives that contain elements other than carbon,
hydrogen, oxygen, nitrogen and sulfur.
The toxicology studies required under Alternative Tier 2 of the
211(b) Rule are based on inhalation exposure to the evaporative
emissions from baseline gasoline or oxygenated gasolines. The
health endpoints included assessments for subchronic toxicity,
neurotoxicity, genotoxicity, immunotoxicity, developmental toxic-
ity, reproductive toxicity, and chronic toxicity/carcinogenicity. The
results of chronic toxicity testing of gasoline and gasoline com-
bined with MTBE have already been reported (Benson et al.,
2011) and reported elsewhere in this issue are the ﬁndings for sub-
chronic toxicity testing (Clark et al., 2014), genotoxicity (Schreiner
et al., 2014), neurotoxicity (O’Callaghan et al., 2014), immunotox-
icity (White et al., 2014), reproductive toxicity (Gray et al., 2014),
and developmental toxicity testing in mice and rats (Roberts
et al., 2014a, 2014b).
Generation of the evaporative emissions described in the origi-
nal 211b rule at CFR 79.57(f)(2) required the construction of an
‘‘evaporative emissions generator (EEG)’’. The EEG was to be ﬁlled
no more than 40% full with the fuel to be tested. The EEG was to be
heated to 130 F and the generated vapor was to be well mixed and
used for inhalation exposures. The size and number of EEGs were
to be varied to adjust the chamber atmosphere concentrations.
No more than 7% of the fuel volume was to be lost during vapor
generation and the fuel in the EEG was to be replaced at the end
of each day. Those original rule requirements imposed signiﬁcant
logistical and safety issues for the toxicology testing facilities and
the Research Group. Because of those issues, the Research Group
undertook development of an alternative method for generating
the evaporative emissions. The alternative method developed to
generate and characterize the test articles used in the toxicology
studies are reported in this paper.2. Methods and materials
The gasoline (e.g., baseline gasoline) used to generate all the
test articles is patterned after the reformulated gasoline summer
baseline fuel as speciﬁed in CAA section 211(k)(10)(B)(i) (40 CFR
79.55). The speciﬁcations and blending tolerances for that gasoline
are listed in Table 1 as well as the actual values for the ﬁrst lot of
baseline gasoline blended.
The additive types included in the CAA baseline gasoline speci-
ﬁcations and the actual treat rates used for this testing program are
also listed in Table 1. The test articles used in the inhalation toxic-
ity studies are vapor condensates prepared from baseline gasoline
and baseline gasoline plus oxygenate blends using the method
described below. The method used to generate the vapor conden-
sate test articles was developed at Chevron Energy Technology
Company (Richmond, CA). Generation of the test articles was done
using commonly accepted petroleum engineering practices.2.1. Baseline gasoline and oxygenate blending
Baseline gasoline meeting CAA requirements was blended by
Phillips 66 Petroleum – Specialty Chemicals (Borger, TX). Over
the duration of the program, three lots of CAA compliant baseline
gasoline were blended. The ﬁrst lot (RF-A-BG) was used to develop
an alternative method for generating the vapor condensate (test
article) to be used in the 211(b) Rule testing. The second lot (API
99-01) was used to splash-blend each of the six gasoline/oxygenate
blends and prepare the vapor condensate test articles for all the
studies described in this series of papers. The oxygenates used
were procured by Phillips 66 Petroleum from various commercialsources and included methyl tert-butyl ether (MTBE), ethyl tert-
butyl ether (ETBE), t-amyl methyl ether (TAME), diisopropyl ether
(DIPE), t-butyl alcohol (TBA), and ethanol (EtOH). The oxygen con-
tent of the various fuel blends was the maximum allowed under
EPA regulations at the time of preparation. For MTBE, ETBE, TAME
and DIPE the oxygen content target was 2.7 wt. %. For EtOH and
TBA the oxygen content target was 3.7 wt. %. The third lot (API
02-08) of baseline gasoline was used to generate additional base-
line gasoline vapor condensate to complete the chronic/carcinoge-
nicity study.2.2. Determining headspace vapor compositions
The compositional target for the test articles made using the
alternative method were determined by analyzing the equilibrium
headspace of sealed 20 ml vials ﬁlled 40% full with baseline gaso-
line or the gasoline/oxygenate blends. This volume was consistent
with the original 1994 CAA 211(b) rule requirement of an ‘‘evapo-
rative emission generator’’ being 40% full at the start of the proce-
dure. Duplicate samples were prepared and analyzed on the same
day. The sealed vials were submerged up to the cap in a 130 F
water bath for 10 min at which time they were inverted three
times and replaced for 5 min more. The headspace vapor composi-
tion was determined by gas chromatography (GC). A Hewlett Pack-
ard 19395A headspace sampler was programmed to withdraw a
headspace sample at this time and transfer it through a heated line
to a gas chromatograph (Hewlett Packard 5890 Series II) equipped
with a non-polar fused silica capillary column. The injection vol-
ume of headspace vapor was 1 mL into 30 psi helium carrier gas
at an injection temperature of 250 C (split ﬂow 200 mL/min).
The oven temperature program is proprietary information.
The material eluting from the column was quantiﬁed using a
ﬂame ionization detector at 250 C (H2 30 mL/min; Air 300 mL/
min). Data was collected by an EZChrom Data System and individ-
ual compounds identiﬁed by proprietary techniques (Chevron SE-
30). Analysis of liquid fuel samples was done with the same gas
chromatography technique but the sample volume injected was
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percent in this paper to facilitate comparisons with data from
ExxonMobil (method described below) that is expressed as area
percent.Table 2
Equilibrium vapor target and test article measured concentrations of fuel oxygenates.
Oxygenate Target concentration
(volume %)a
Reference concentration
(area %)b
TAME 10.6 11.92.3. Large scale vapor condensate generation
To produce the quantity of vapor condensate test articles neces-
sary to complete the 211(b) Alternative Tier 2 Testing program, a
large scale batch method was developed. It required ﬁlling a
glass-lined 1000 gallon kettle (Pfaudler, Rochester, NY) with
approximately 800 gallons of baseline gasoline or gasoline/oxygen-
ate blend. The sample was slowly heated and stirred for up to 72 h
as the liquid temperature was raised to approximately 150 F,
resulting in a vapor temperature of approximately 130 F. The
vapor leaving the kettle traveled downward to a chilled receiver
vessel were it was condensed and collected as liquid. Additional
vapor traps chilled in dry ice/isopropanol captured any the remain-
ing vapor that didn’t condense in the receiver. The chilled conden-
sate from the receiver and additional trap material were then
uniformly mixed, transferred to 5-gallon or 70-gallon LPG-type
containers (Manchester Tank, Franklin, TN) and shipped to the tox-
icology testing laboratories as required. For the G/ETBE and G/DIPE
vapor condensates, butylated hydroxytoluene (Sigma–Aldrich) was
added at a concentration of 10 ppm to prevent formation of oxy-
genate peroxides.EtOH 12.4 13.3
ETBE 14.2 16.3
TBA 14.3 16.5
DIPE 16.5 17.8
MTBE 19.3 21.3
a Chevron SE-30.
b ExxonMobil.
Table 3
Carbon number distribution of whole and vaporized gasoline.a
Carbon
number
Whole baseline
gasoline (volume %)
Equilibrium
vapor at 130 F
(volume %)
Baseline gasoline
vapor condensate
(volume %)
3 0 0 0.1
4 4.7 27.1 20.6
5 16.3 40.9 46.4
6 18.5 18.8 21.6
7 19.1 8.0 9.0
8 20.2 4.0 2.2
9 10.6 0.8 0.2
10 6.0 0.2 0
11 2.8 0 0
12 1.8 0 0
a Chevron SE-30.
Table 4a
Chemical characterization of whole and vaporized gasoline.a
Physical chemical
parameter
Whole
RF-A-BG
gasoline
RF-A-BG
equilibrium
vapor at 130 F
Baseline gasoline
vapor condensate
test article
Parafﬁns (volume %) 47.5 79.5 76.6
Oleﬁns (volume %) 9.4 12.1 13.8
Cycloparafﬁns (volume %) 6.0 2.8 5.9
Aromatics (volume %) 34.3 5.5 3.7
Benzene (volume %) 1.4 1.0 1.2
Number of constituents 380 242 131
Average molecular weight 95.9 73.2 73.8
Speciﬁc gravity 60/60 0.752 0.650 0.651
a Chevron SE-30 analysis.2.4. Analysis of vapor condensate samples
A sample of each vapor condensate was sent to ExxonMobil
Biomedical Sciences, Inc., (Annandale, NJ) for compositional analy-
sis using a method that could be adapted by multiple toxicology
testing facilities. Eighteen hydrocarbons and the six oxygenates
were chosen as the reference analytes to be quantiﬁed. The analy-
sis procedures followed US EPA Good Laboratory Practice
Standards (40 CFR Part 79.60, 1994). Initially a gas chromatogra-
phy–ﬂame ionization detector method was developed using a
Supelco Petrocol DH 150 capillary column (150 m  0.25 mm;
1.0 lm ﬁlm thickness). It used a 0.5 uL injection volume of vapor
condensate (plus 1 uL of a reference compound mixture) into a
Perkin Elmer XL Autosystem with an injector temperature of
225 C (split ﬂow 370 mL/min) and helium carrier gas at 65 psi.
The oven temperature program was 35 C hold 130 min; ramp @
2 C/minute to 200 C. The detector temperature was 225 C
(H2:air ratio of 45:450 mL/min). Data collection was done using a
Perkin Elmer Nelson Turbochrom instrument. Using those instru-
ment conditions, this method was capable of resolving each of
the 18 reference hydrocarbons from each other and from four of
the six oxygenates. A second method using a Supelco Petrocol
DH Octyl capillary column (100 m  0.25 mm; 0.5 lm ﬁlm thick-
ness) was used to separate the MTBE/2,3-dimethylbutane and
the DIPE/n-hexane pairs that could not be resolved on the Petrocol
DH 150 capillary column. The instrument conditions for this
second method are identical to the ﬁrst except for a lower helium
carrier gas pressure of 40 psi.
The results of the ExxonMobil GLP-compliant method were
used to establish the reference composition for the test articles.
The results are expressed as ‘‘area percent’’ to facilitate comparison
among multiple laboratories. The analytical measurements of the
vapor condensates by the toxicology testing facilities also con-
formed to GLP-requirements and analysis for the individual hydro-
carbons were consistent with those measured by ExxonMobil. This
paper summarizes the compositional data obtained by both the
non-GLP method (Chevron SE-30) and the GLP-compliant method
(ExxonMobil).3. Results
Analysis of the equilibrium vapor in the headspace of 20 ml
vials at 130 F provided the target concentration of the various
oxygenates desired during the large scale batch preparations.
Table 2 shows those target concentrations and the measured con-
centration of oxygenate achieved in the test articles. The rank-
order of the oxygenate concentration in the equilibrium vapor
and the test article was maintained by the large scale batch process
used by the Research Group.
Table 3 compares the carbon number distribution of whole
baseline gasoline with its 130 F equilibrium vapor and the base-
line gasoline vapor condensate test article.
Table 4a compares the hydrocarbon types and other properties
of whole gasoline with its equilibrium vapor and the baseline gas-
oline vapor condensate test article. Key differences between whole
gasoline and the vaporized gasoline are the signiﬁcantly greater
concentration of C4 and C5 constituents and depletion of C7–C12
aromatic constituents in the vapor condensate. The equilibrium
Table 4b
Chemical characterization of the vapor condensate test articles.a
Physical chemical parameter Baseline gasoline G/EtOH G/TBA G/MTBE G/ETBE G/TAME G/DIPE
Parafﬁns (volume %) 76.6 67.4 63.5 59.5 63.1 66.2 63.3
Oleﬁns (volume %) 13.8 12.6 13.5 12.5 13.2 14.2 12.8
Cycloparafﬁns (volume %) 5.9 2.0 3.3 2.2 2.7 3.0 2.4
Aromatics (volume %) 3.7 2.5 4.4 3.2 3.8 4.4 3.5
Benzene (volume %) 1.2 0.9 1.3 1.0 1.1 1.2 1.1
Oxygenate (volume %) 0 15.4 15.4 22.7 17.2 12.2 17.9
Average molecular weight 73.8 65.9 72.1 73.7 77.1 77.2 76.5
Speciﬁc gravity 60/60 0.651 0.665 0.678 0.668 0.669 0.670 0.663
a Chevron SE-30 analysis.
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average molecular weight and speciﬁc gravity. Table 4b compares
the hydrocarbon types and other properties of all the test articles
used in the testing program.
Using a large scale batch process at a single location allowed the
Research Group to safely produce the large quantities of test article
required. The magnitude of the operation is evident from the vol-
umes shown in Table 5. Over ﬁfty-ﬁve thousand gallons of whole
gasoline was required to make almost ten thousand gallons of test
article(s).
To help achieve consistency in the GC analysis between several
toxicology testing facilities, a reference method conducted under
GLP procedures was developed by ExxonMobil. As part of that
development effort, a comparison of results between the Chevron
SE-30 method and the ExxonMobil method was done.Table 5
Percentage of whole gasoline recovered as vapor condensate by a large scale batch
process.
Whole gasoline Vapor condensate Percentage (%)
Baseline gasoline 20,356 gallons 3332 gallons 16
G/EtOH 4028 gallons 616 gallons 15
G/TBA 4052 gallons 966 gallons 23
G/MTBE 15300 gallons 2723 gallons 17
G/ETBE 3916 gallons 719 gallons 18
G/TAME 4022 gallons 826 gallons 20
G/DIPE 3903 gallons 630 gallons 16
Total quantities 55,577 gallons 9812 gallons
Table 6
Results of baseline gasoline vapor condensate analysis by two gas chromatography
methods.
Compound Chevron SE-30 ExxonMobil
(Volume-percent)a (Area-percent)
Isobutane 4.0 2.8
n-Butane 15.4 13.1
Isopentane 34.8 34.8
n-Pentane 13.1 13.7
Trans-2-pentene 2.6 2.6
2-Methyl 2-butene 3.8 3.9
2,3-Dimethylbutane 1.7 1.7
2-Methylpentane 5.9 6.8
3-Methylpentane 3.5 3.9
n-Hexane 3.2 3.1
Methylcyclopentane 1.7 1.6
2,4-Dimethylpentane 1.1 1.1
Benzene 1.6 2.2
2-Methylhexane 1.2 1.2
2,3-Dimethylpentane 1.3 1.2
3-Methylhexane 1.3 1.4
Isooctane 1.5 1.5
Toluene 2.2 3.3
Analysis of sample RF-A-BG.
a These compounds are normalized to 100%.The results in Table 6 demonstrate that the two GC methods are
comparable for the 18 hydrocarbons speciated by the ExxonMobil
method. For that comparison the Chevron SE-30 data for those 18
hydrocarbons was normalized to 100%. The Chevron SE-30 method
actually separated and quantiﬁed 131 peaks from the baseline gas-
oline vapor condensate. Those 18 hydrocarbons made up over 81%
of the sample volume.
The results of the ExxonMobil analysis of the seven test articles
are shown in Table 7. The vapor condensate from the three lots of
baseline gasoline are similar. Only the second lot (API 99-01) was
used to prepare the test articles used in the studies reported in this
series of papers. The toxicology testing facilities were required to
periodically perform similar GC analysis on the chamber air to con-
ﬁrm that they consistently achieved an atmosphere of completely
‘‘re-vaporized’’ test article over the duration of the study.4. Discussion
The original EPA method required the inhalation test atmo-
sphere of ‘‘evaporative emissions’’ to be generated from whole
gasoline in situ at the toxicology testing laboratory. The logistic
and safety issues associated with that requirement prompted
the Research Group to develop an alternative method. The
method developed by the Research Group was submitted to
EPA for approval before the start of the Alternative Tier 2 testing
program. The advantages of the alternative method included: (1)
the handling and heating of large quantities of gasoline were
done at a petroleum company research facility with technical
staff who routinely handle ﬂammable materials, (2) by adding
nitrogen gas under slight pressure to the 5-gallon LPG-type con-
tainer, the toxicology testing facilities could continuously meter
out the amount of test article necessary, wholly re-vaporize it,
and introduce the vapor into the exposure chambers, (3) the
vapor condensate test material provided adequate inhalation
exposure concentrations (e.g., up to 50% of the lower explosive
limit), (4) the test material atmosphere was uniform throughout
the exposure duration at all the toxicology testing laboratories,
and (5) the vapor condensate composition was more similar to
the 130 F equilibrium vapor composition than the vapor
achieved using the method described in the original rule (data
not presented, see EPA Docket, 1997).
To test the proposed alternative evaporative emissions genera-
tion method, API sponsored a developmental toxicity evaluation of
unleaded gasoline vapor condensate in the rat outside the CAA
211b test rule (Roberts et al., 2001). The success of that study
and the advantages of the alternative method persuaded EPA to
approve the Research Group’s proposed methodology as part of
the Alternative Tier 2 Rulemaking (EPA Docket, 1998). The test arti-
cles generated and characterized by the methods described were
used at three different toxicology testing facilities to conduct the
testing required by the Alternative Tier 2 Fuel and Fuel Additive
regulations.
Table 7
Reference method analysis of vapor condensate test articles.
Compounds RF-A-BG
Baseline gasoline
API 99-01
Baseline gasoline
API 02-08
Baseline gasoline
G/EtOH G/TBA G/MTBE G/ETBE G/TAME G/DIPE
Isobutane 2.8 3.6 2.1 2.2 3.0 2.2 2.0 1.9 2.0
n-Butane 13.1 15.2 19.9 11.6 9.9 11.1 10.6 10.4 11.5
Isopentane 34.8 35.1 32.1 34.0 25.2 31.0 32.5 33.6 32.2
n-Pentane 13.7 13.2 5.4 10.2 11.6 9.1 9.8 10.3 9.6
t-2-Pentene 2.6 2.5 2.4 2.1 2.1 2.0 2.1 2.3 2.1
2-Methyl-2-butene 3.9 3.8 3.3 3.1 3.2 2.9 3.2 3.4 3.1
2,3-Dimethylbutane 1.7 1.6 6.2 2.2 1.6 0.9 1.4 1.5 1.3
2-Methylpentane 6.8 6.3 9.6 5.1 6.1 4.5 5.1 5.6 4.5
3-Methylpentane 3.9 3.6 6.8 2.9 3.8 2.6 2.9 3.2 2.7
n-Hexane 3.1 3.0 1.2 2.4 3.4 2.1 2.4 2.6 1.8
Methylcyclopentane 1.6 1.5 0.7 1.2 1.6 1.1 1.3 1.4 1.0
2,4-Dimethylpentane 1.1 1.0 0.6 1.0 1.0 0.9 1.0 1.2 1.0
Benzene 2.2 2.1 1.9 1.6 2.0 1.5 1.8 2.0 1.8
2-Methylhexane 1.2 1.1 1.7 1.1 1.3 1.0 1.1 1.2 1.1
2,3-Dimethylpentane 1.2 1.1 1.0 1.1 1.3 1.0 1.1 1.3 1.1
3-Methylhexane 1.4 1.3 2.3 1.2 1.5 1.1 1.3 1.5 1.3
Isooctane 1.5 1.3 0.7 1.3 1.5 1.2 1.4 1.5 1.4
Toluene 3.3 3.0 2.6 2.4 3.4 2.5 2.7 3.2 2.6
EtOH 13.3
TBA 16.5
MTBE 21.3
ETBE 16.3
TAME 11.9
DIPE 17.8
Values reported as area percent.
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